Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study
Background: Current use of menopausal hormone therapy (HT) increases the risk of venous thromboembolism (VTE) and the formulations used may affect risk. Methods: A total of 1058259 postmenopausal UK women were followed by record linkage to routinely collected National Health Service hospital admission and death records. HT use and risk of VTE was examined using Cox regression to estimate relative risks (RRs) and 95% confidence intervals (CIs). Results: During 3.3 million years of follow-up,...[Show more]
|Collections||ANU Research Publications|
|Source:||Journal of thrombosis and haemeostasis|
|01_Sweetland_Venous_thromboembolism_risk_in_2012.pdf||243.43 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.